single nucleotide polymorphism reference database (Celera)
Structured Review
Single Nucleotide Polymorphism Reference Database, supplied by Celera, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+snp+data/single+nucleotide+polymorphisms/pm12754702-71-10-19
Average 90 stars, based on 1 article reviews
Images
Related Articles
Sequencing:Article Title: Identifying calcineurin activators for treatment of schizophrenia Article Snippet: .. For this study we utilized some of the Article Title: Genetic regulatory network analysis for app based on genetical genomics approach. Article Snippet: .. Single-Nucleotide Polymorphisms (SNPs) for App Sequences for App from the public mouse assembly database (mm8, February 2007 release; http://genome.ucsc.edu) were mapped onto the Celera mouse assembly by Blat (Kent, 2002) to obtain the Article Title: Aggrecanase molecules Article Snippet: .. The Celera other:Article Title: Polymorphisms and noncardioembolic stroke in three case-control studies. Article Snippet: Background: Gene variants associated with disease could reveal novel mechanisms.. We searched for single nucleotide polymorphisms (SNPs) associated with noncardioembolic stroke (nonCES).. Methods: We tested 24,926 SNPs in or near genes for association with nonCES in the Vienna Study (551 cases, 815 controls) and then evaluated the associated SNPs in the UCSF-CC Study (570 cases, 1,604 controls) first in pooled DNA samples and then in individual DNA samples. Article Title: Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Article Snippet: The third American Associated for the Study of Liver Diseases (AASLD)–sponsored Single Topic Conference on hepatic fibrosis was held in June 2006.. The conference was both international, with 6 countries represented, and cross-disciplinary, linking the basic molecular and cellular biology of fibrogenic cells to clinical trial design for emerging antifibrotic therapies.. The specific goals of the conference were: (1) to consolidate knowledge about the natural history of fibrosis; (2) to clarify potential endpoints and markers; (3) to emphasize new antifibrotic targets developed on the basis of advances in basic science; and (4) to understand current critical issues pertaining to clinical trial design. Article Title: Current understanding of the genetic aetiology of rheumatoid arthritis and likely future developments. Article Snippet: We also describe an extensive analysis of functional single-nucleotide polymorphisms (SNPs) that is under way in collaboration with |
